“I don't have time to do this.”
“I don’t want to risk patient privacy.”
“I’m concerned about the legal issues.”
When asked why they aren’t active on social media, oncology professionals often have objections like these.
But Dr. Don Dizon thinks that ignoring social media simply isn’t an option anymore. And he’s taking huge steps to remedy the disconnect.
Dr. Don Dizon , is a Professor of Medicine at Brown University and the Director of the Breast and Pelvic Malignancies Program at Lifespan Cancer Institute. He also formed a crowdsourced organization called Collaboration for Outcomes Using Social Media in Oncology (COSMO).
Some might call him a social media “power user” — and for good reason. He’s active on multiple platforms, and he’s on a mission to highlight the dangers of misinformation online, and how healthcare professionals can help change those narratives and sculpt conversations around health and research.
And of course, there are the wonderful benefits of a social media presence, like personal branding, thought leadership, and networking.
Don’t miss this one!
Here are the show highlights
- One of the most crucial lessons to take away from this whole conversation (7:10)
- Join the fight against misinformation and false narratives (16:31)
- Here’s the first step to finding the right social media platform and getting started (24:40)
- There’s a niche for everything. Learn how to filter down tweets to find content you’re interested in (26:35)
- Why you need more “Twiends” (Twitter friends!) (30:35)
Check out these resources mentioned during the podcast:
Stay connected with Working in Oncology on Apple Podcasts, Spotify, or our podcast website.
Guest Bio
Don S. Dizon is an oncologist who specializes in breast and pelvic cancers particularly survivorship and sex following a cancer diagnosis. He is a trialist interested in novel therapies and writes about experiences in medicine as an oncologist. He is passionate about communications and the use of social media. He is a professor of medicine at Brown University and Director of Clinical Oncology at Rhode Island Hospital.
